Announcements Trials
Browse Landscape

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 145Observational 4

Sponsor

Cancer Type

Breast 8Thoracic 4CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Locally Advanced/ Metastatic NSCLC 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 30Drug Therapy 27Immunotherapy 25Surgical Procedures, Operative 22Carboplatin 22Nivolumab 21Immune Checkpoint Inhibitors 20pembrolizumab 18osimertinib 18atezolizumab 17Observation 17Radiotherapy 16Bevacizumab 15Cisplatin 14Afatinib 14Specimen Handling 13Gene Expression Profiling 13Erlotinib Hydrochloride 13lorlatinib 12Pemetrexed 12Magnetic Resonance Spectroscopy 11Ipilimumab 11Immunohistochemistry 11Biopsy 11durvalumab 10alectinib 10Paclitaxel 10Bronchoscopy 10Tomography, X-Ray Computed 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Vinorelbine × Thoracic × Clear all
NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Sungkyunkwan University

Unknown
4,724 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04208854 2019-12-26

VINORELBINA

International Group of Endovascular Oncology

Unknown
40 enrolled
Thoracic

Locally Advanced/ Metastatic NSCLC

NCT02619929 2018-08-29

StepUp

Pierre Fabre Pharma GmbH

Completed
108 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01752517 2012-12-19

Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer

Peking Union Medical College Hospital

Unknown
60 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡